MTM stands for Medication Therapy Management, which is a service provided by pharmacists, medical affairs, and RWE scientists to help people better understand their medications and improve outcomes. MTM is not prescription dispensing or disease management, but rather a range of services provided to individual patients to optimize therapeutic outcomes. MTM services include comprehensive medication reviews and targeted medication reviews, which are used to assess medication use and issues needing attention. MTM encourages patients to be active participants in their healthcare, empowering them to be more knowledgeable about and responsible for their health and medication use.

MTM programs are required by the US Centers for Medicare and Medicaid Services for Part D plans, and are provided free to eligible patients enrolled in a plan. To be eligible, a patient must have at least two (or three, for some plans) chronic conditions, take multiple drugs covered by Part D, and are predicted to exceed a preset amount in annual out of pocket costs for their covered Part D drugs. Plans are permitted to expand MTM eligibility to patients not meeting the minimum required criteria if they so choose.

MTM services contribute to the safe, appropriate, and effective use of medications and offer value by improving the quality of patient care and outcomes, reducing healthcare expenditures, and reducing medication-related adverse events. MTM is essentially a medication-focused approach to optimizing a patients drug therapy and regimen, but it can come up short in its narrow focus on medications as the baseline for interventions.